Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myozyme in Infantile-Onset Pompe Disease
NCT00059280Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Primary completion
- Jun 2005
- Countries
- 5
01
Overview
A Phase 3 trial of alglucosidase alfa in Pompe disease, sponsored by Sanofi. Started Apr 2003; status: completed.
02
Drugs
alglucosidase alfa
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT00059280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059280.